1. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP);Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2013
2. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2014;Reagan-Steiner;MMWR Morb Mortal Wkly Rep,2015
3. Licensure of meningococcal conjugate vaccine (Menveo) and guidance for use – Advisory Committee on Immunization Practices (ACIP), 2010;Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2010
4. Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease – Advisory Committee on Immunization Practices (ACIP);Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2011
5. Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices;Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2014